The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis

Background: Consensus United States cervical cancer screening guidelines recommend use of combination Pap plus human papillomavirus (HPV) testing for women aged 30 to 65 years. An HPV test was approved by the Food and Drug Administration in 2014 for primary cervical cancer screening in women age 25...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix, Juan C., Lacey, Michael J., Miller, Jeffrey D., Lenhart, Gregory M., Spitzer, Mark, Kulkarni, Rucha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900245/
https://www.ncbi.nlm.nih.gov/pubmed/27023044
http://dx.doi.org/10.1089/jwh.2015.5708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900245/
https://www.ncbi.nlm.nih.gov/pubmed/27023044
http://dx.doi.org/10.1089/jwh.2015.5708

Ejemplares similares